China biologic products holdings, inc. (CBPO)
Income statement / TTM
Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
External customers

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Sales

344,891

347,034

341,169

331,819

324,043

311,691

296,457

286,160

276,333

257,339

243,251

227,856

212,085

205,591

203,356

194,760

194,731

191,617

184,813

186,470

174,649

165,848

153,092

153,443

153,048

0

0

0

External customers

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Cost of sales

120,834

122,206

124,034

120,194

120,492

116,064

106,482

100,494

94,906

86,771

80,025

74,570

69,380

66,582

65,484

59,973

59,728

59,737

58,835

59,186

56,040

52,421

46,017

44,281

39,565

0

0

0

Gross profit

224,056

224,828

217,134

211,624

203,551

195,626

189,975

185,665

181,427

170,567

163,226

153,285

142,704

139,009

137,872

134,787

135,003

131,880

125,977

127,283

118,609

113,427

107,074

109,162

113,482

0

0

0

Operating expenses
Selling expenses

14,810

14,259

11,679

10,014

9,672

9,250

9,973

9,904

9,651

10,375

10,707

11,846

11,976

11,089

10,643

8,713

9,708

11,431

14,421

17,940

18,099

16,971

14,595

11,421

9,574

0

0

0

General and administrative expenses

60,138

58,447

54,519

52,903

49,318

44,866

41,391

37,552

33,775

32,766

32,129

31,365

32,850

34,603

36,073

34,128

36,509

35,575

34,034

34,957

31,468

31,201

31,519

29,072

26,867

0

0

0

Research and development expenses

7,905

7,284

7,021

5,481

6,033

5,776

6,024

3,445

3,638

4,430

4,161

6,122

5,387

4,383

4,223

3,556

3,140

3,235

3,032

3,816

3,688

3,977

3,978

2,871

3,679

0

0

0

Impairment loss of goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

Loss on abandonment and write-off of long-lived assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

Income from operations

141,202

144,836

143,914

143,225

138,527

135,733

132,585

129,695

129,294

117,926

111,158

103,952

92,490

88,932

86,932

88,387

85,645

81,638

74,489

70,405

40,590

36,512

32,217

41,197

73,361

0

0

0

Other income (expenses)
Equity in income/(loss) of an equity method investee

4,359

3,647

2,519

967

-506

-1,432

-1,311

5,732

6,024

8,213

8,646

2,564

3,291

2,378

2,170

1,829

1,931

1,772

2,665

2,631

2,598

2,610

1,858

1,769

1,214

0

0

0

Change in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,769

-1,317

1,546

12,162

11,974

18,853

18,260

0

0

0

Interest income

8,013

7,688

7,815

6,232

5,750

5,925

5,551

5,828

6,168

6,425

6,644

6,512

6,109

5,381

4,433

4,003

3,245

3,014

2,910

2,314

2,226

1,730

1,356

1,136

843

0

0

0

Interest expense

426

228

254

428

471

1,059

1,727

2,699

3,646

3,833

3,697

2,925

2,184

1,519

1,134

1,021

938

897

1,269

1,274

1,455

3,598

4,670

5,120

4,097

0

0

0

Loss from disposal of a subsidiary

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

570

-1,113

-1,627

-779

-453

1,148

1,315

0

0

0

Total other income, net

11,871

11,031

10,004

6,696

4,772

3,433

2,512

8,861

8,546

10,806

11,593

6,150

7,216

6,240

5,468

5,034

4,911

5,121

6,645

3,380

5,429

12,573

10,065

15,362

13,667

0

0

0

Income before income tax expense

153,073

155,868

153,919

149,921

143,299

139,167

135,098

138,557

137,840

128,732

122,752

110,102

99,707

95,172

92,401

93,422

90,556

86,759

81,135

73,786

46,020

49,086

42,282

56,560

87,029

0

0

0

Income tax expense

25,329

25,469

25,125

23,978

22,866

21,983

20,992

27,599

28,554

26,917

26,639

19,148

17,012

16,271

15,540

18,396

17,005

16,593

15,163

10,286

7,829

9,813

10,899

13,976

17,915

0

0

0

Net income

127,743

130,398

128,793

125,942

120,432

117,183

114,105

110,957

109,285

101,815

96,112

90,954

82,695

78,901

76,861

75,026

73,551

70,166

65,971

63,499

38,190

39,273

31,383

42,583

69,113

0

0

0

Less: Net income attributable to noncontrolling interest

18,892

21,824

24,014

24,321

24,326

25,105

25,062

25,336

26,481

26,009

25,195

24,067

21,172

20,941

22,259

23,443

23,047

22,985

20,749

19,451

17,121

14,443

13,201

15,303

19,535

0

0

0

Net income attributable to China Biologic Products Holdings, Inc.

108,851

108,573

104,779

101,621

96,106

92,077

89,042

85,621

82,804

75,805

70,916

66,886

61,522

57,959

54,601

51,582

50,503

47,180

45,222

44,047

21,069

24,830

18,181

27,280

49,577

0

0

0

Earnings per share of ordinary share:
Basic

1.10

1.07

0.69

1.02

1.12

0.96

0.58

0.86

1.05

0.91

0.50

0.80

0.83

0.72

0.35

0.55

0.60

0.55

0.21

0.51

0.50

0.51

0.17

-0.37

0.67

0.26

0.58

0.55

Diluted

1.09

1.06

0.69

1.01

1.10

0.94

0.59

0.82

0.99

0.87

0.47

0.76

0.79

0.69

0.33

0.53

0.57

0.53

0.22

0.50

0.46

0.44

0.23

-0.37

0.28

0.23

0.39

0.41

Weighted average shares used in computation:
Basic

27,213

27,183

27,151

26,957

26,698

26,585

26,567

25,992

25,019

24,816

24,727

24,548

23,483

24,950

25,689

26,288

26,880

26,785

26,590

26,546

25,875

25,601

25,580

25,551

24,632

24,351

23,513

23,511

Diluted

27,478

27,465

27,420

27,297

27,152

27,126

26,825

27,056

26,320

26,066

26,101

25,787

24,719

26,132

26,856

27,449

28,067

27,915

27,164

27,018

26,627

26,547

28,648

25,551

26,738

25,680

26,578

26,599

Net income

127,743

130,398

128,793

125,942

120,432

117,183

114,105

110,957

109,285

101,815

96,112

90,954

82,695

78,901

76,861

75,026

73,551

70,166

65,971

63,499

38,190

39,273

31,383

42,583

69,113

0

0

0

Other comprehensive income/(losses):
Foreign currency translation adjustment, net of nil income taxes

-7,192

-31,152

-31,303

-23,513

-35,675

-20,944

-24,368

-14,299

1,279

343

-1,918

-1,399

711

4,613

9,126

8,319

6,247

1,955

1,735

2,182

4,334

6,897

6,846

0

0

0

-

-

Comprehensive income

120,551

99,246

97,490

102,428

84,757

96,238

89,737

96,658

110,565

102,159

94,193

89,554

83,406

83,514

85,987

83,345

79,798

72,121

67,707

65,682

42,524

46,170

38,230

0

0

0

-

-

Less: Comprehensive income attributable to noncontrolling interest

17,089

16,698

19,026

20,209

17,859

21,221

20,698

22,773

26,839

26,148

24,798

23,809

21,314

21,897

23,951

24,940

24,279

23,306

21,163

20,042

18,773

16,548

15,320

0

0

0

-

-

Comprehensive income attributable to China Biologic Products Holdings, Inc.

103,461

82,548

78,463

82,219

66,898

75,017

69,038

73,884

83,726

76,010

69,395

65,745

62,092

61,616

62,035

58,405

55,518

48,814

46,543

45,639

23,751

29,621

22,909

0

0

0

-

-